2025-07-25 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided, presented in a report format with key numbers and analysis, followed by a comprehensive summary.

**Report: Albemarle Corp (ALB) Analysis**

**Date:** July 27, 2025

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ALB
*   **Company Description:** Albemarle Corp is a specialty chemicals company, primarily focused on lithium, bromine specialties, and catalysts.
*   **ALB Cumulative Return:** 39.92%
*   **VOO Cumulative Return:** 98.88%
*   **Spread (ALB - VOO):** -58.7
*   **Relative Spread Position:** 7.8 (Indicates ALB's current spread position relative to its historical range)

**Analysis:** ALB has significantly underperformed the S&P 500. The spread of -58.7 indicates a considerable difference in cumulative returns. A relative spread position of 7.8 suggests that the current underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha    | Beta     | Cap(B) |
| ---------- | -------- | -------- | -------- | -------- | ------ |
| 2015-2017  | 99.0%    | 8.1%     | 70.0%    | 0.0      | 15.1   |
| 2016-2018  | 13.0%    | 58.0%    | -5.0%    | 0.0      | 9.1    |
| 2017-2019  | -44.0%   | 58.0%    | -74.0%   | -0.0     | 8.6    |
| 2018-2020  | 101.0%   | 62.9%    | 81.0%    | 0.6      | 17.4   |
| 2019-2021  | 268.0%   | 62.9%    | 220.0%   | 0.6      | 27.5   |
| 2020-2022  | 239.0%   | 75.6%    | 237.0%   | 0.8      | 25.5   |
| 2021-2023  | -53.0%   | 77.5%    | -71.0%   | 0.6      | 17.0   |
| 2022-2024  | -200.0%  | 77.5%    | -225.0%  | 0.7      | 10.1   |
| 2023-2025  | -308.0%  | 77.5%    | -359.0%  | 3.0      | 9.9    |

**Analysis:**

*   **CAGR:** Fluctuates significantly, with high growth periods followed by substantial declines.
*   **MDD:**  Maximum Drawdown is consistently high, indicating significant volatility and risk.
*   **Alpha:** Demonstrates periods of strong outperformance (high positive Alpha) and significant underperformance (large negative Alpha) relative to its benchmark.  The most recent periods show severe underperformance.
*   **Beta:** Beta values are generally low, suggesting low systematic risk exposure.
*   **Cap:** Market Cap varies significantly.

**2. Recent Price Action**

*   **Current Price:** $84.18
*   **Previous Close:** $78.79
*   **Change:** 6.84 (+6.84)
*   **5-day Moving Average:** $80.09
*   **20-day Moving Average:** $71.46
*   **60-day Moving Average:** $63.33

**Analysis:** The stock price has recently experienced a significant increase, as evidenced by the large change from the previous close and the fact that the current price is above all three moving averages. This suggests a short-term upward trend.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 71.41 (Overbought)
*   **PPO:** 1.41
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **20-day Relative Spread Change:** 4.9 (Positive, indicating short-term improvement)
*   **Expected Return:** 1388.4% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a low-risk environment, which could be misleading given the stock's recent volatility.
*   The RSI indicates that the stock is currently overbought, suggesting a potential pullback.
*   The PPO indicates that the stock is above its average, which is a positive sign.
*   The Hybrid Signal suggests being cautious.
*   The large "change" figure (6.84) confirms a recent sharp upward price movement, potentially indicating a volatile situation.
*   The extremely high expected return should be viewed with skepticism.  It represents a theoretical long-term outperformance relative to the S&P 500 but is likely based on specific models and assumptions and doesn't guarantee actual future results.

**4. Recent News & Significant Events**

*   **2025-07-22:** Major business developments, regulatory changes, or market events affecting Albemarle Corp.
*   **2025-07-25:** Analyst discussions on recent performance, industry trends, and global economic factors.
*   **2025-07-24:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-21:** Market experts highlighting risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** The news suggests that Albemarle is currently subject to significant market attention and volatility, driven by recent events and analyst speculation.

**5. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출        |
| ---------- | ------ | ----------- |
| 2025-04-30 | 0      | 1.08 B$     |
| 2024-11-06 | -9.45  | 1.35 B$     |
| 2024-07-31 | -1.96  | 1.43 B$     |
| 2024-05-01 | -0.08  | 1.36 B$     |
| 2025-04-30 | -0.08  | 1.36 B$     |

**Analysis:**

The company has experienced a drop in EPS(Earning Per Share), with recent quarters showing losses. The most recent data show revenue decline and zero EPS.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | ------------- |
| 2025-03-31   | $1.08B     | 14.51%        |
| 2024-12-31   | $1.23B     | 11.22%        |
| 2024-09-30   | $1.35B     | -7.68%        |
| 2024-06-30   | $1.43B     | -0.74%        |
| 2024-03-31   | $1.36B     | 2.86%         |

**Capital and Profitability**

| Quarter      | Equity     | ROE       |
| ------------ | ---------- | --------- |
| 2025-03-31   | $10.03B    | 0.41%     |
| 2024-12-31   | $9.96B     | 0.76%     |
| 2024-09-30   | $10.24B    | -10.44%   |
| 2024-06-30   | $11.22B    | -1.68%    |
| 2024-03-31   | $11.53B    | 0.02%     |

**Analysis:**

*   **Revenue:** Revenue has generally been declining over the past year.
*   **Profit Margin:** Profit margins have fluctuated and turned negative in recent quarters, indicating potential profitability concerns.
*   **Equity:** Equity has decreased, reflecting potential challenges in maintaining shareholder value.
*   **ROE:** ROE has been weak and negative in some quarters, suggesting inefficient use of equity to generate profits.

**7. Overall Summary**

Albemarle Corp (ALB) is currently exhibiting a mixed picture.

*   **Negative Factors:**
    *   Significant underperformance compared to the S&P 500.
    *   High Maximum Drawdown values in the Alpha/Beta analysis indicate volatility.
    *   Recent earnings reports showing losses.
    *   Declining revenue and negative profit margins.
    *   Negative ROE.
*   **Positive Factors:**
    *   Recent positive price momentum, as evidenced by the large "change" and the price being above its moving averages.
    *   The MRI indicates low risk, although this might be misleading considering the recent volatility.
    *   High expected return(However, this should be cautiously interpreted, and doesn't guarantee actual future results.)

**Conclusion:**

ALB is a high-risk, potentially high-reward investment at the moment. The recent price surge and "low risk" MRI need to be balanced against the company's fundamental challenges in revenue, profitability, and earnings.  The high "expected return" is speculative and should not be the sole basis for investment decisions.

**Recommendation:**

Given the conflicting signals, a **cautious** approach is warranted. Investors should closely monitor news, earnings announcements, and analyst reports to gauge the company's future prospects. Consider the stock to be overbought.

**Disclaimer:** This analysis is based on the provided data and is for informational purposes only. It is not financial advice, and investors should conduct their own due diligence before making any investment decisions.
